Specialty Pharma ApS Financials, key figures and credit report
Gross profit 216.7 kDKK FY 2025 +124.8% vs 2024
EBIT -70.7 kDKK FY 2025 -16.6% vs 2024
Net debt -57.5 kDKK FY 2025 -10.3% vs 2024
Quick ratio 0.8 FY 2025 -0.5 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 639.30 | 1 023.44 | 292.69 | 96.40 | 216.74 |
| Employee benefit expenses | - 704.77 | - 963.49 | - 183.75 | - 157.05 | - 287.47 |
| EBIT | -65.47 | 59.94 | 108.94 | -60.66 | -70.74 |
| Other financial expenses | -0.50 | -1.70 | -2.49 | -0.36 | |
| Pre-tax profit | -65.97 | 58.24 | 108.94 | -63.14 | -71.10 |
| Income taxes | 21.74 | -17.12 | -28.25 | 9.38 | 12.53 |
| Net earnings | -44.23 | 41.13 | 80.69 | -53.76 | -58.57 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 18.82 | 128.25 | 96.13 | 6.39 | |
| Current deferred tax assets | 21.74 | 2.62 | 9.38 | 21.92 | |
| Short term receivables total | 21.74 | 21.44 | 128.25 | 105.51 | 28.31 |
| Other current investments | 18.00 | 18.00 | 18.00 | ||
| Cash and bank deposits | 101.85 | 94.34 | 34.07 | 34.18 | 39.53 |
| Cash and cash equivalents | 101.85 | 94.34 | 52.07 | 52.18 | 57.53 |
| Balance sheet total (assets) | 123.59 | 115.78 | 180.33 | 157.69 | 85.83 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | -33.08 | -77.31 | -36.18 | 44.51 | -9.25 |
| Profit of the financial year | -44.23 | 41.13 | 80.69 | -53.76 | -58.57 |
| Shareholders equity total | -27.31 | 13.82 | 94.51 | 40.75 | -17.82 |
| Non-current liabilities total | |||||
| Short-term deferred tax liabilities | 25.63 | ||||
| Other non-interest bearing current liabilities | 150.90 | 101.96 | 60.19 | 116.94 | 103.65 |
| Current liabilities total | 150.90 | 101.96 | 85.82 | 116.94 | 103.65 |
| Balance sheet total (liabilities) | 123.59 | 115.78 | 180.33 | 157.69 | 85.83 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated